SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2023-12-27 23:44
Tx date 2023-12-08
$LSL
LSL Pharma Group Inc.
Roberge, François
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
$
+$85,000 vol
$10.00 each
$85,000
Filed 2023-12-08 14:41
Tx date 2023-12-08
$LSL
LSL Pharma Group Inc.
Roberge, François
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
$
+$8,500 vol
$10.00 each
Filed 2023-12-08 14:41
Tx date 2023-12-08
$LSL
LSL Pharma Group Inc.
Roberge, François
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures
16 - Acquisition or disposition under a prospectus exemption
$
+$8,500 vol
$10.00 each
$8,500
Filed 2023-12-08 14:35
Tx date 2023-02-22
$LSL
LSL Pharma Group Inc.
Roberge, François
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Convertible Debentures
00 - Opening Balance-Initial SEDI Report
Filed 2023-03-04 06:33
Tx date 2023-02-22
$LSL
LSL Pharma Group Inc.
Mainville, Luc
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+150,000 vol
150,000
Filed 2023-03-04 00:53
Tx date 2023-02-22
$LSL
LSL Pharma Group Inc.
Richer, Sylvain
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
750,000
Filed 2023-03-04 00:53
Tx date 2023-02-22
$LSL
LSL Pharma Group Inc.
Richer, Sylvain
5 - Senior Officer of Issuer
Holder: Placements Sylvain Richer Inc. (Indirect Ownership)
Common Shares catégorie A
00 - Opening Balance-Initial SEDI Report
1,000,000
Filed 2023-03-04 00:45
Tx date 2023-02-22
$LSL
LSL Pharma Group Inc.
Boudreault, Marc
5 - Senior Officer of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
750,000
Filed 2023-03-04 00:45
Tx date 2023-02-22
$LSL
LSL Pharma Group Inc.
Boudreault, Marc
5 - Senior Officer of Issuer
Direct Ownership
Common Shares catégorie A
00 - Opening Balance-Initial SEDI Report
1,013,000
Filed 2023-03-04 00:44
Tx date 2023-02-22
$LSL
LSL Pharma Group Inc.
Boudreault, Marc
5 - Senior Officer of Issuer
Holder: Fiducie Boudreault Decoste (Indirect Ownership)
Common Shares catégorie A
00 - Opening Balance-Initial SEDI Report
1,480,000
Filed 2023-03-04 00:34
Tx date 2023-02-22
$LSL
LSL Pharma Group Inc.
Pierre B., Lafrenière
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
150,000
Filed 2023-03-04 00:04
Tx date 2023-02-22
$LSL
LSL Pharma Group Inc.
Aird, Sylvain
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
150,000
Filed 2023-03-04 00:04
Tx date 2023-02-22
$LSL
LSL Pharma Group Inc.
Aird, Sylvain
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report
35,714
Filed 2023-03-04 00:03
Tx date 2023-02-22
$LSL
LSL Pharma Group Inc.
Aird, Sylvain
4 - Director of Issuer
Direct Ownership
Common Shares catégorie A
00 - Opening Balance-Initial SEDI Report
71,428
Filed 2023-03-03 23:54
Tx date 2023-02-22
$LSL
LSL Pharma Group Inc.
Roberge, François
3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
Common Shares catégorie A
00 - Opening Balance-Initial SEDI Report
4,748,000
Filed 2023-03-03 23:48
Tx date 2023-02-22
$LSL
LSL Pharma Group Inc.
Dellafera, Frank J.
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report
250,000
Filed 2023-03-03 23:47
Tx date 2023-02-22
$LSL
LSL Pharma Group Inc.
Dellafera, Frank J.
4 - Director of Issuer
Holder: Alfera Pharmaceuticals, LLC (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report
21,428
Filed 2023-03-03 23:47
Tx date 2023-02-22
$LSL
LSL Pharma Group Inc.
Dellafera, Frank J.
4 - Director of Issuer
Holder: Alfera Pharmaceuticals, LLC (Indirect Ownership)
Common Shares catégorie A
00 - Opening Balance-Initial SEDI Report
42,857
Filed 2023-03-03 16:48
Tx date 2023-02-22
$LSL
LSL Pharma Group Inc.
Mainville, Luc
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+150,000 vol
Filed 2023-03-03 16:48
Tx date 2023-02-22
$LSL
LSL Pharma Group Inc.
Mainville, Luc
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options

+150,000 vol
150,000
Filed 2023-03-03 07:12
Tx date 2023-02-22
$LSL
LSL Pharma Group Inc.
Mainville, Luc
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report